Systematic review / meta-analysis / 2016
Higher BMI was linked to increased all-cause mortality, with the lowest mortality observed at a BMI of 20 to 24 depending on smoking and health status.
A systematic review and meta-analysis of 230 cohort studies evaluated the dose-response relationship between BMI and all-cause mortality. For each 5-unit increase in BMI, the summary relative risk for all-cause mortality was 1.18 (95% CI 1.15 to 1.21) in never smokers, 1.21 (1.18 to 1.25) in healthy never smokers, 1.27 (1.21 to 1.33) in healthy never smokers excluding early follow-up, and 1.05 (1.04 to 1.07) across all participants. A J-shaped dose-response relation appeared in never smokers (Pnon-linearity <0.001), with the lowest mortality risk at BMI 23-24 in never smokers, 22-23 in healthy never smokers, and 20-22 in studies with >=20 years of follow-up. A U-shaped curve emerged in analyses of all participants, smokers, studies with <5 or <10 years of follow-up, or moderate quality scores, which authors noted could be biased by residual confounding from preclinical disease.
Shows an association, not proof of cause and effect.
- Study type
- Dose-response meta-analysis of cohort studies
- Who was studied
- 30,233,329 participants (>3,744,722 deaths) across 230 cohort studies, including >9,976,077 never smokers (>738,144 deaths)
- What was measured
- All-cause mortality
THE PAPER
BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants.
Aune D, Sen A, Prasad M, Norat T, Janszky I, Tonstad S, Romundstad P, Vatten LJ. BMJ, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.